August 26, 2025
Crypto

Peter Thiel-Backed Crypto Exchange Snubs London Listing Amid Liquidity Concerns, Weighs Frankfurt Or New York: Report – Grayscale Bitcoin Mini Trust (BTC) Common units of fractional undivided beneficial interest (ARCA:BTC)


European cryptocurrency exchange Bitpanda has decided against a potential listing in London due to concerns about liquidity in the city’s capital markets, according to a report published late Monday.

Bitpanda Gives London A Miss

The Austrian-based cryptocurrency exchange, one of the largest in Europe, is considering a listing. However, London will not be the chosen location, co-founder Eric Demuth told the Financial Times.

“Currently, liquidity-wise, the LSE [London Stock Exchange] is not doing too well,” Demuth was quoted as saying. “I hope that it gets better, but over the next few years, I think the LSE is struggling a bit,”

Demurg added that the firm is considering listing in either Frankfurt or New York, but no final decision on location or timing has been made.

The London Stock Exchange didn’t immediately return Benzinga’s request for comment.

See Also: Palantir, Peter Thiel Targets Of Protest Groups That Took On Elon Musk, Tesla: ‘People Over Billionaires’

Peter Thiel’s Strategic Bets On Crypto Exchanges

Founded in 2014, the Vienna-based firm allows users to trade leading cryptocurrencies, such as Bitcoin BTC/USD and Ethereum ETH/USD. It is backed by billionaire investors Peter Thiel and Alan Howard.

Interestingly, Bullish BLSH, another cryptocurrency exchange backed by Thiel, successfully debuted on Wall Street earlier this month. The company opened for trading at $90.45 per share, well-above its initial public offering price of $37 per share.

The stock exhibited a moderately high Value score — a metric that evaluates a stock’s relative worth by comparing its market price to fundamental measures of the company. Visit Benzinga Edge Stock Rankings to compare it with Coinbase Global Inc. COIN, the biggest cryptocurrency exchange in the U.S.

Read Next: 

Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.

Image via Shutterstock



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. View more
Accept
Decline